The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia
AIDSPublished 30 March 2008
Máirín Ryan, Susan Griffin, Bona Chitah, A Sarah Walker, Veronica Mulenga, Donald Kalolo
Citations48
SJR quartileQ1
SJR score1.21
SNIP0.90
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Cotrimoxazole prophylaxis in HIV-infected children is an inexpensive low technology intervention that is highly cost-effective in Zambia, strongly supporting the adoption of WHO guidelines into essential healthcare packages in low-income countries.
Abstract
Cotrimoxazole prophylaxis in HIV-infected children is an inexpensive low technology intervention that is highly cost-effective in Zambia, strongly supporting the adoption of WHO guidelines into essential healthcare packages in low-income countries.
Keywords
Medicine
Decision Modelling For Health Economic Evaluation
3,113 Citations2006Andrew Briggs, Karl Claxton +1 more
This book deals with decision modelling techniques that can be used to estimate the value for money of various interventions including medical devices, surgical procedures, diagnostic technologies, and pharmaceuticals.
PubMedQuantifying the burden of disease: the technical basis for disability-adjusted life years.
1,570 Citations1994Chris Murray
The LancetMortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis
1,170 Citations2004Marie‐Louise Newell, Hoosen Coovadia +4 more
Findings highlight the necessity for timely antiretroviral care for support for HIV-infected women and children in developing countries, and for assessment of prophylactic programmes to prevent MTCT, including child mortality and infection averted.
New England Journal of MedicineCost-Effectiveness of Screening for HIV in the Era of Highly Active Antiretroviral Therapy
608 Citations2005Gillian D Sanders, Ahmed M. Bayoumi +8 more
The cost-effectiveness of routine HIV screening in health care settings, even in relatively low-prevalence populations, is similar to that of commonly accepted interventions, and such programs should be expanded.
Health Policy and PlanningCalculating QALYs, comparing QALY and DALY calculations
571 Citations2006Franco Sassi
This paper provides a comprehensive formulation of QALY calculation methods, offering practical instruments for assessing the impact of health interventions, similar to those made available elsewhere for calculating DALYs.
The LancetEfficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial
425 Citations1999Stefan Z. Wiktor, Madeleine Sassan‐Morokro +17 more
In HIV-1-infected patients with tuberculosis, daily co-trimoxazole prophylaxis was well tolerated and significantly decreased mortality and hospital admission rates.
The LancetEarly chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial
409 Citations1999Xavier Anglaret, Geneviève Chêne +7 more
Co-trimoxazole was generally well tolerated though moderate neutropenia occurred in 62 patients (vs 26 in the placebo group) and the benefit was apparent in all subgroups of initial CD4-cell count.
The LancetCost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence
400 Citations2002Andrew Creese, Katherine Floyd +2 more
A strong economic case exists for prioritisation of preventive interventions and tuberculosis treatment and where potentially exclusive alternatives exist, cost-effectiveness analysis points to an intervention that offers the best value for money.
The LancetCo-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial
382 Citations2004Chifumbe Chintu, G.K. Bhat +10 more
The results suggest that children of all ages with clinical features of HIV infection should receive co-trimoxazole prophylaxis in resource-poor settings, irrespective of local resistance to this drug.
Health Policy and PlanningCalculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis
382 Citations2001J. F. Rushby
This paper shows how to calculate DALYs for cost-effectiveness analysis using a worked example, shows the impact of changing the age weighting and discount rates on estimates of cost- Effectiveness, and suggests a set of minimum reporting criteria for using DALys in cost-Effectiveness analysis.
The LancetEffect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda
343 Citations2004Jonathan Mermin, John Lule +12 more
Daily co-trimoxazole prophylaxis was associated with reduced morbidity and mortality and had beneficial effects on CD4-cell count and viral load and is a readily available, effective intervention for people with HIV infection in Africa.
The LancetCost-effectiveness of malaria control in sub-Saharan Africa
277 Citations1999Catherine Goodman, P. G. Coleman +1 more
Using mathematical models to calculate cost-effectiveness ratios for the main prevention and treatment interventions in sub-Saharan Africa, it is found that a package of interventions to decrease the bulk of the malaria burden is not, however, affordable in very-low-income countries.
New England Journal of MedicineCost-Effectiveness of HIV Treatment in Resource-Poor Settings — The Case of Côte d'Ivoire
272 Citations2006Sue J. Goldie, Yazdan Yazdanpanah +9 more
A strategy of trimethoprim-sulfamethoxazole prophylaxis and antiretroviral therapy, with the use of clinical criteria alone or in combination with CD4 testing to guide the timing of treatment, is an economically attractive health investment in settings with limited resources.
Journal of Health Services Research & PolicySearching for a threshold, not setting one: the role of the National Institute for Health and Clinical Excellence
176 Citations2007Anthony J. Culyer, Christopher McCabe +6 more
The task for NICE is as a 'threshold-searcher' to seek to identify an optimal threshold incremental cost-effectiveness ratio, at the ruling rate of expenditure, that is consistent with the aim of the health service to maximize population health.
Medical Decision MakingA Meta-Analysis of Utility Estimates for HIV/AIDS
161 Citations2002Tammy O. Tengs, Ting Hsiang Lin
The authors performed a meta-analysis to derive pooled utilities for HIV/AIDS and to assess the relative importance of study design characteristics in predicting utilities, finding disease stage, elicitation method, respondent type, and the upper-bound and lower-bound labels for the utility scale as the independent variables significant.
BMJMethods to assess the costs and health effects of interventions for improving health in developing countries
143 Citations2005David Evans, Tessa Tan-Torres Edejer +2 more
How the standardised cost effectiveness methods used in the World Health Organization’s Choosing Interventions that are Cost Effective (CHOICE) project have tackled these issues are described.
Disability and RehabilitationThe health-related quality of life of people living with HIV/AIDS
124 Citations2004Janeen Hughes, Jennifer Jelsma +3 more
Self-reporting indicates that Health Related Quality of Life is severely comprised in PLWA in Stages 3 and 4 and limitations in the four domains of mobility, usual activities, pain/discomfort and anxiety/depression constitute major problems for PLWA.
PEDIATRICSFluctuations in Symptoms in Human Immunodeficiency Virus-Infected Children: The First 10 Years of Life
124 Citations2001The European Collaborative Study
AIDSClinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d’Ivoire: a trial-based analysis
80 Citations2005Yazdan Yazdanpanah, Elena Losina +8 more
For HIV-infected adults in Côte d’Ivoire, co-trimoxazole prophylaxis is reasonably cost-effective and most effective if initiated when WHO stage ≥ 2, and should be considered an essential component of care for early HIV in sub-Saharan Africa.
JAIDS Journal of Acquired Immune Deficiency SyndromesDeterminants of Survival Without Antiretroviral Therapy After Infancy in HIV-1-Infected Zambian Children in the CHAP Trial
70 Citations2006A Sarah Walker, Veronica Mulenga +5 more
Malnutrition and hospitalizations for respiratory/bacterial infections predict mortality independent of immunosuppression, suggesting that they capture HIV- and non-HIV-related mortality, whereas oral candidiasis is a proxy for immunos Puppression.
AIDSEffect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children
68 Citations2006Veronica Mulenga, Deborah Ford +10 more
Cotrimoxazole prophylaxis appears to mainly reduce death and hospital admissions from respiratory infections, supported further by lower rates of antibiotic prescribing.
PLoS ONECost-Effectiveness of Genotypic Antiretroviral Resistance Testing in HIV-Infected Patients with Treatment Failure
46 Citations2007Parham Sendi, Huldrych F. Günthard +5 more
GRT for treatment optimization in HIV-infected patients with treatment failure is a cost-effective use of scarce health care resources and beneficial to the society at large.
Medical Decision MakingCost-Effectiveness Analysis of Treatments for Chronic Disease: Using R to Incorporate Time Dependency of Treatment Response
44 Citations2005Neil Hawkins, Mark Sculpher +1 more
A novel approach to building time dependency into a Markov model by incorporating an additional time dimension resulting in a “semi-Markov” model is described.
Emerging infectious diseasesAntimicrobial Sensitivity in Enterobacteria from AIDS Patients, Zambia
32 Citations2002James Mwansa, Kabanga Mutela +3 more
Reduced sensitivity of enterobacteria to available antimicrobial agents in Zambia is reported, with only 22% of nontyphoidal salmonellae and 6% of shigellae sensitive to SXT.
JAIDS Journal of Acquired Immune Deficiency SyndromesCost-Effectiveness of Cotrimoxazole Prophylaxis Among Persons With HIV in Uganda
30 Citations2007Christian Pitter, James G. Kahn +7 more
Daily cotrimoxazole prophylaxis for HIV-infected individuals is highly cost-effective in rural Uganda and the use of screening algorithms to identify individuals with advanced HIV disease may result in higher program costs and less favorable cost-effectiveness.
AIDSThe costs and benefits of private sector provision of treatment to HIV-infected employees in Kampala, Uganda
22 Citations2006Elliot Marseille, Joseph Saba +2 more
A ‘hybrid’ intervention combining CTX prophylaxis followed by HAART would generate savings to a Ugandan company and governments and other donors may find opportunities to share costs with the private sector as part of their phase-in strategy for antiretroviral therapy.